TREM2 and metabolic dysfunction-associated steatotic liver disease: Conversely, the overexpression of Trem2 in macrophages improved MASLD, suggesting that Trem2 is a potential target for MASLD treatment by regulating hepatocyte‒macrophage metabolic coordination [38].